医学部内視鏡センター

Medicine & Life Sciences

1. Ulcerative Colitis 100%
2. Crohn Disease 47%
3. Capsule Endoscopy 41%
4. Inflammatory Bowel Diseases 34%
5. Endoscopic Mucosal Resection 32%
6. Colitis 29%
7. Capsule Endoscopes 25%
8. Colonoscopy 24%
9. Infliximab 21%
10. Colon 20%
11. Endoscopy 20%
12. Stomach 20%
13. Mesalamine 19%
14. Hemorrhage 18%
15. Mucous Membrane 16%
16. Therapeutics 13%
17. vedolizumab 13%
18. Neoplasms 12%
19. Single-Balloon Enteroscopy 12%
20. Safety 12%
21. T-Lymphocytes 11%
22. Inflammation 10%
23. Adenoma 10%
24. Confidence Intervals 10%
25. Prospective Studies 10%
26. Indigo Carmine 10%
27. Japan 10%
28. Capsules 10%
29. Lymphocytes 9%
30. Feasibility Studies 9%
31. Small Intestine 9%
32. Steroids 9%
33. Pancreatitis 8%
34. Placebos 8%
35. Randomized Controlled Trials 8%
36. Adalimumab 8%
37. Recurrence 7%
38. Intraepithelial Lymphocytes 7%
39. Colorectal Neoplasms 7%
40. Stomach Neoplasms 7%
41. Ulcer 7%
42. Gastrointestinal Tract 7%
43. Surgical Instruments 7%
44. Intestinal Diseases 7%
45. Polyps 7%
46. Balloon Enteroscopy 7%
47. Dextran Sulfate 7%
48. Th1 Cells 6%
49. Ileum 6%
50. Gastrointestinal Microbiome 6%
51. Tacrolimus 6%
52. Organoids 6%
53. Pathologic Constriction 6%
54. Sigmoid Colon 6%
55. Genes 6%
56. Blood Component Removal 6%
57. Interleukin-7 6%
58. Biopsy 6%
59. Epithelial Cells 6%
60. Gastrointestinal Endoscopy 6%
61. Pancreatic Neoplasms 5%
62. Endoscopic Hemostasis 5%
63. Dendritic Cells 5%
64. Intestinal Mucosa 5%
65. Immunologic Factors 5%
66. Antibodies 5%
67. Intestines 5%
68. Regulatory T-Lymphocytes 5%
69. Adenocarcinoma 5%
70. Maintenance 5%
71. Water 5%
72. Interferons 5%
73. Gastroscopy 5%
74. Double-Blind Method 5%
75. Odds Ratio 5%